You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
11 March 2026 - Drug company Curatis Holding AG and Japanese pharmaceutical company Neupharma Co, Ltd announced on Wednesday that they have signed an exclusive licensing and development agreement to commercialise corticorelin (C-PTBE-01) for the trea...
11 March 2026 - Oncology-focused biopharmaceutical company Citius Oncology Inc (Nasdaq:CTOR), a majority-owned subsidiary of Citius Pharmaceuticals Inc (Nasdaq:CTXR), on Tuesday reported positive topline results from a completed investigator-initiate...
11 March 2026 - Precision medicine software company GenomOncology announced on Tuesday that it has partnered with WeTrials, an AI-powered patient engagement and trial enablement platform, to help central nervous system (CNS) cancer patients access an...
10 March 2026 - Immuno-oncology company Agenus Inc (Nasdaq:AGEN) said on Tuesday that it has triggered the first USD20m contingent payment under its strategic collaboration with Zydus Lifesciences Ltd.The payment was activated through contracted work...
10 March 2026 - Medical technology company HeartBeam Inc (NASDAQ:BEAT) on Tuesday announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai in New York to accelerate the development and validation of next-generation AI-ECG ...
10 March 2026 - Medicomp Systems, a provider of clinical data solutions, announced on Monday that its customer, Institut Jantung Negara (IJN), the National Heart Institute of Malaysia, has been granted Stage 7 validation by the Healthcare Information...